{"sourcedb":"DevicePMAs@therightstef","sourceid":"P900030_S000","text":"Approval for the Contigen Bard Collagen Implant.  This device is indicated for use in the treatment of urinary incontinence due to intrinsic sphincter deficiency (poor or non-functioning bladder outlet mechanism) that may be helped by a locally injected bulking agent.  Contigen implant therapy is intended only for patients who have shown no improvement in their incontinence for at least 12 months.","project":"consensus_PMA_Age_Indications"}